SUMMARY The concentration of 170H-progesterone was measured in amniotic fluid samples collected from 55 mothers who had previously had a child with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. In eight pregnancies the levels of 170H-progesterone were raised; the parents elected to terminate in four and examinations of the fetus confirmed the diagnosis of congenital adrenal hyperplasia. In each case, the affected sib was a salt loser. The remaining four affected pregnancies proceeded to term and each infant had salt losing 21-hydroxylase deficiency. All 47 infants predicted to be unaffected were normal at birth. However, an increased plasma concentration of 170H-progesterone was documented in a male non-salt loser at three months of age.
Congenital adrenal hyperplasia is an autosomal recessive disorder of steroid biosynthesis due to deficiency of the enzyme 21-hydroxylase in more than 90% of cases.' The increased concentration of 170H-progesterone in the blood provides a rapid and reliable test for the disorder at birth.2 3The fetal adrenal gland synthesises steroids from early gestation4; consequently the prenatal diagnosis of congenital adrenal hyperplasia can be established in pregnancies at risk by measurement of increased concentrations of 170H-progesterone in amniotic fluid.99
The majority of patients with congenital adrenal hyperplasia are salt losers due to a deficiency in both glucocorticoid and mineralocorticoid biosynthesis. The remainder are classified as either simple virilisers, late onset, and cryptic or non-classical cases.'( A recent review of published cases detected prenatally suggested that only the salt losing variant was identified by an increased concentration of 170H-progesterone in amniotic fluid. " We report our experience with the use of this test in a large number of pregnancies at risk of fetal 21- The mean concentration of 170H-progesterone in second trimester amniotic fluid from normal pregnancies was 18*5 nmol/l (5-2 SD). In 47 term pregnancies at risk with normal infants at birth, there was no significant difference in mean amniotic fluid 170H-progesterone concentration (17-1 nmol/l, 6-3 SD, p>0.1). There was a significant increase (p<O-OOl) in mean 170H-progesterone concentration in amniotic fluid from known affected pregnancies 
OUTCOME OF PREGNANCIES TESTED
Four of the eight affected pregnancies were terminated before 20 weeks' gestation at the request of the parents. All three female fetuses showed evidence of virilisation with fused labia and a single urogenital opening at the base of an enlarged clitoris (fig 2) . The external genitalia of the affected male fetus were normal but the combined weight of the adrenal glands (2.4 g) was increased for gestational age (in normals, the mean combined weight is 1P2 g with 95% confidence intervals of 0-6 to 1-7 g).l4 HLA typing of amniotic cells was identical to the haplotype in the affected sib and concurred with a raised 170H-progesterone concentration (55 nmol/1).
The remaining four pregnancies proceeded to term. A male infant was delivered in each case and 21-hydroxylase deficiency was confirmed by a raised plasma 170H-progesterone concentration. The pattern of plasma electrolyte concentrations was consistent with each infant being a salt loser. A male infant, one of the 47 infants normal at birth, was investigated at three months of age because of scrotal pigmentation. In the eight pregnancies where the fetus was known to be affected by 21-hydroxylase deficiency, the concentration of 170H-progesterone in amniotic fluid was clearly raised. The salt losing variant of congenital adrenal hyperplasia was a common factor in all these cases; this was confirmed in four infants delivered at term. The affected sibs of all four aborted fetuses were also salt losers. Of the 55 pregnancies at risk for fetal 21-hydroxylase deficiency, 14 5% were affected compared to an expected incidence of 25% for an autosomal recessive disorder. However, in the larger group predicted to be unaffected and with normal infants at birth, there was one male non-salt loser proven to be affected at three months of age. In this instance the proband was also a non-salt loser. However, the accepted dogma that the simple virilising or salt losing variant breeds true within a family is challenged by the recent observation of non-concor- 
